Literature DB >> 9307167

Gender and the sudden infant death syndrome. New Zealand Cot Death Study Group.

E A Mitchell1, A W Stewart.   

Abstract

A nationwide case-control study compared the prevalence and magnitude of risk factors for sudden infant death syndrome (SIDS) in male and female infants. The risk factors of SIDS and their magnitude for males and females are very similar. After adjustment for potential confounders male infants had a 1.42-fold (95% CI = 1.04, 1.94) increased risk of SIDS compared with females. Risk factors identified in most epidemiological studies are not the reason for the increased SIDS mortality seen in male infants.

Entities:  

Mesh:

Year:  1997        PMID: 9307167     DOI: 10.1111/j.1651-2227.1997.tb08611.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

Review 1.  Pediatric origins of adult lung diseases. 3: the genesis of adult sleep apnoea in childhood.

Authors:  F McNamara; C E Sullivan
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

2.  Sudden infant death syndrome: exposure to cigarette smoke leads to hypomethylation upstream of the growth factor independent 1 (GFI1) gene promoter.

Authors:  Kristina Schwender; Hannah Holtkötter; Kristina Schulze Johann; Alina Glaub; Marianne Schürenkamp; Ulla Sibbing; Sabrina Banken; Mechtild Vennemann; Heidi Pfeiffer; Marielle Vennemann
Journal:  Forensic Sci Med Pathol       Date:  2016-09-27       Impact factor: 2.007

3.  Association between monoamine oxidase A promoter polymorphism and the risk of sudden infant death syndrome: a meta-analysis.

Authors:  Qiaoxia Zhou; Daoyin Gong; Yu Zhang; Feijun Huang
Journal:  Int J Legal Med       Date:  2021-02-01       Impact factor: 2.686

Review 4.  Impact of inflammation on developing respiratory control networks: rhythm generation, chemoreception and plasticity.

Authors:  Sarah A Beyeler; Matthew R Hodges; Adrianne G Huxtable
Journal:  Respir Physiol Neurobiol       Date:  2019-12-30       Impact factor: 2.821

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.